Panettieri, Reynold A <br/><br/>
Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study.  [electronic resource] 

 -  Clinical therapeutics  Aug 2009 
 - 1716-23 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2009.08.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-Agonists--administration & dosage<br/>Aged<br/>Area Under Curve<br/>Bronchodilator Agents--administration & dosage<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Ethanolamines--administration & dosage<br/>Female<br/>Forced Expiratory Volume--drug effects<br/>Formoterol Fumarate<br/>Humans<br/>Least-Squares Analysis<br/>Male<br/>Middle Aged<br/>Nebulizers and Vaporizers<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Severity of Illness Index<br/>Time Factors